eWeLL Co.,Ltd.
Fiscal Year Ending December 2026, Second Quarter (Interim) Financial Summary (Japan GAAP) (Consolidated)
For the first half of the fiscal year ending December 2026, net sales were 1.991 billion yen (YoY +24.2%), operating income 946.63 million yen (YoY +20.1%), ordinary income 953.124 million yen (YoY +20.4%), and net income attributable to owners of the parent for the interim period was 663.891 million yen (YoY +21.1%). There are no changes to the full-year earnings forecast for the fiscal year ending December 2026. A financial results briefing is planned.
Key Figures
- Sales: 1,991,274千円（YoY +24.2％増）
- Operating income: 946,631千円（YoY +20.1％増）
- Interim net income: 663,891千円（YoY +21.1％増）
AI要約
Business performance overview
During this interim period, demand for digital transformation (DX) in home-visit nursing and for AI-enabled workflow optimization remained high. Revenues increased mainly due to the main product, the electronic medical record for home-visit nursing, iBow. Expansion of AI-related services and management analysis features supported solid new customer acquisitions, and the increase in contracted stations helped reinforce sales.
Outlook and financial position
As of the interim period-end, cash and cash equivalents stood at approximately 28.1 million yen, and the equity ratio rose to 81.4%. The full-year earnings forecast remains unchanged from the February 2026 release. Since the segment is a single business, segment-specific details are omitted. A financial results briefing is planned for institutional and individual investors.
株式会社ｅＷｅＬＬ
Company overview · Stock price · Financial data · All IR
